Formulus Use Case - Montelukast Sodium

Pharmaceutical Industry Use Case

Developing medicines to treat asthma can be time consuming and a complex process. This is especially true in pediatric medicine where children prefer oral alternatives to inhalers. 

Formulators frequently start with baseline ingredient, montelukast sodium (CAS RN 151767-02-1) to make these drugs. To encourage patient compliance, it is necessary to include excipients specifically to help make montelukast sodium palatable.. Learn how Formulus can help speed up the process. 

Formulus Information Request Form

Your privacy is important to CAS. More detail about how we use your information is in our privacy policy.